Future GLP-1 trends: new drugs and therapies on the horizon The future of weight management may soon involve more than current GLP-1s: Amylin mimetics: These compounds mimic another satiety hormone and may complement GLP-1s. Mazdutide: A dual glucagon/GLP-1 agonist showing strong Phase 3 results and promising greater weight loss. Oral GLP-1s: Pills in development could improve convenience. Muscle-preserving combinations: Researchers are exploring co-therapies to prevent loss of lean mass during weight loss. Providers should prepare for a rapidly evolving landscape and educate patients about upcoming options. Key takeaways on GLP-1 trends for providers and patients Efficacy varies across drugs and doses
Weve shared the recommended injection sites for Mounjaro and a simple step-by-step guide on administering the injection pen properly
10.1073/pnas.1603244113 179 YangY.-K.WangL.-P.ChenL.YaoX.-P.YangK.-Q.GaoL.-G.et al (2015)
Effects of normal synovial fluid and interferon gamma on chondrogenic capability and Immunomodulatory potential respectively on equine mesenchymal stem cells
In one study, tumor-bearing mice that received ashwagandha root exhibited reductions in tumor cell counts and tumor weight, as well as a 27.5% increase in lifespan, compared with tumor-bearing mice that did not receive ashwagandha (Winters 2006)
53 Stressful experiences and trauma, including events that provoke fear and anxiety, increase the reactivity of the HPA axis and promote the release of pro-inflammatory cytokines
-(1).png?sfvrsn=c236e848_3)
